XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
OPERATING ACTIVITIES    
Net (loss) income $ 1,253,000 $ (2,098,000)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Gain on sales (1,047,000)  
Impairment charges   7,474,000
Straight-line rents and expenses, net (103,000) (16,000)
Provision for doubtful accounts 68,000 53,000
Depreciation and amortization 11,211,000 13,747,000
Amortization of intangible lease liabilities, net (277,000) (459,000)
Expense relating to share-based compensation, net 880,000 1,014,000
Amortization of deferred financing costs 342,000 310,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Rents and other receivables (1,845,000) (953,000)
Prepaid expenses and other (2,234,000) (2,507,000)
Accounts payable and accrued liabilities 1,294,000 (3,176,000)
Net cash provided by operating activities 9,542,000 13,389,000
INVESTING ACTIVITIES    
Expenditures for real estate improvements (6,949,000) (9,813,000)
Net proceeds from sales of real estate 1,248,000  
Net cash (used in) investing activities (5,701,000) (9,813,000)
FINANCING ACTIVITIES    
Repayments under revolving credit facility (2,000,000) (7,000,000)
Advances under revolving credit facility 6,000,000 83,000,000
Mortgage repayments (273,000) (263,000)
Payments of debt financing costs (2,476,000)  
Noncontrolling interests:    
Distributions to limited partners (5,000) (27,000)
Common stock sales less issuance expenses, net 1,000 5,000
Preferred stock dividends (2,688,000) (2,688,000)
Distributions to common shareholders (899,000) (4,468,000)
Net cash (used in) provided by financing activities (2,340,000) 68,559,000
Net increase in cash, cash equivalents and restricted cash 1,501,000 72,135,000
Cash, cash equivalents and restricted cash at beginning of year 1,637,000 2,747,000
Cash, cash equivalents and restricted cash at end of year 3,138,000 74,882,000
Reconciliation to consolidated balance sheets:    
Cash and cash equivalents 3,138,000 74,882,000
Cash, cash equivalents and restricted cash at end of year $ 3,138,000 $ 74,882,000